Huang, X., Qi, L., Lu, W., Li, Z., Li, W., & Li, F. (2021). MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4. Taylor & Francis Group.
Chicago Style (17th ed.) CitationHuang, Xianbao, Ling Qi, Wei Lu, Ziye Li, Wuping Li, and Fei Li. MYCN Contributes to the Sensitization of Acute Myelogenous Leukemia Cells to Cisplatin by Targeting SRY-box Transcription Factor 4. Taylor & Francis Group, 2021.
MLA (8th ed.) CitationHuang, Xianbao, et al. MYCN Contributes to the Sensitization of Acute Myelogenous Leukemia Cells to Cisplatin by Targeting SRY-box Transcription Factor 4. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.